FrancophonIA/ELRC3.0 huggingface dataset:
English: Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems.
Croatian: Olanzapin je antipsihotik, lijek za liječenje manije i stabilizaciju raspoloženja, koji pokazuje farmakološki profil širokog spektra preko brojnih receptorskih sustava.
English: What you need to know before you take Olanzapine Mylan
Croatian: Što morate znati prije nego počnete uzimati Olanzapine Mylan
English: PHARMACEUTICAL FORM Film-coated tablet (tablet).
Croatian: OBLIK Filmom obložena tableta (tableta).
English: • medicines for Parkinson's disease.
Croatian: • lijekove protiv Parkinsonove bolesti,
English: Dementia-related psychosis and/or behavioural disturbances Olanzapine is not recommended for use in patients with dementia-related psychosis and/or behavioural disturbances because of an increase in mortality and the risk of cerebrovascular accident.
Croatian: Psihoza i/ili poremećaji ponašanja uzrokovani demencijom Primjena olanzapina se ne preporučuje u bolesnika s psihozom i/ili poremećajima ponašanja uzrokovanima demencijom zbog porasta mortaliteta i rizika od pojave cerebrovaskularnog događaja.
English: However, as clinical experience with olanzapine in patients with concomitant illness is limited, caution is advised when prescribing for patients with prostatic hypertrophy, or paralytic ileus and related conditions.
Croatian: Međutim, kako je kliničko iskustvo s olanzapinom u bolesnika s konkomitantnom bolesti ograničeno, savjetuje se oprez u propisivanju bolesnicima s hipertrofijom prostate ili paralitičkim ileusom i povezanim stanjima.
English: In the study, the risk of olanzapine was comparable to the risk of atypical antipsychotics included in a pooled analysis.
Croatian: U ispitivanju, rizik olanzapina bio je usporediv s rizikom za atipične antipsihotike uključene u kombiniranu analizu.
English: Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental status, and evidence of autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresis, and cardiac dysrhythmia).
Croatian: Kliničke manifestacije NMS-a su hiperpireksija, rigidnost mišića, promijenjen mentalni status te dokaz autonomne nestabilnosti (nepravilan puls ili krvni tlak, tahikardija, dijaforeza i poremećaji srčanog ritma).
English: Hyperglycaemia and/or development or exacerbation of diabetes occasionally associated with ketoacidosis or coma has been reported uncommonly, including some fatal cases (see section 4.8).
Croatian: Hiperglikemija i/ili razvoj ili egzacerbacija dijabetesa koji su bili povremeno povezani s ketoacidozom ili komom prijavljuju se manje često, uključujući neke smrtne slučajeve (vidjeti dio 4.8).
English: Age >75 years and vascular/mixed type dementia were identified as risk factors for CVAE in association with olanzapine treatment.
Croatian: Dob starija od 75 godina i demencija vaskularnog/miješanog tipa bili su prepoznati kao čimbenici rizika za CV događaje povezane s liječenjem olanzapinom.
English: Pharmaceutical Trading Co. Ltd. Τηλ: +357 99403969
Croatian: Ltd. Τηλ: +357 99403969
English: Common: Elevated cholesterol levels15
Croatian: Često: Povišene razine kolesterola15
English: In two of two placebo and two of three comparator controlled trials with over 2,900 schizophrenic patients presenting with both positive and negative symptoms, olanzapine was associated with statistically significantly greater improvements in negative as well as positive symptoms.
Croatian: U dva od dva placebom kontrolirana ispitivanja te u dva od tri usporedna kontrolirana ispitivanja s preko 2900 bolesnika sa shizofrenijom koji su imali i pozitivne i negativne simptome olanzapin je bio povezan sa statistički značajnim poboljšanjem negativnih i pozitivnih simptoma.
English: Very common: Elevations of hepatic aminotransferases (ALT/AST; see section 4.4).
Croatian: Vrlo često: Povišene razine jetrenih aminotransferaza (ALT/AST; vidjeti dio 4.4).
English: Do not use epinephrine, dopamine, or other sympathomimetic agents with beta agonist activity since beta stimulation may worsen hypotension.
Croatian: Uz aktivne beta-agoniste ne koristite epinefrin, dopamin ni druge simpatomimetike jer beta-stimulacija može pogoršati hipotenziju.
English: High Gamma Glutamyltransferase10
Croatian: visoka gama glutamiltransferaza1
English: The concomitant administration of activated charcoal was shown to reduce the oral bioavailability of olanzapine by 50 to 60 %.
Croatian: Pokazalo se da istodobna primjena aktivnog ugljena smanjuje oralnu bioraspoloživost olanzapina za 50 do 60 %.
English: Very rare side effects include serious allergic reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
Croatian: Vrlo rijetke nuspojave uključuju ozbiljne alergijske reakcije poput reakcije na lijek s eozinofilijom i sistemskim simptomima (engl.
English: Sedation affected mating performance of male rats.
Croatian: Sedacija je utjecala na sposobnost parenja mužjaka štakora.
English: Thus no particular interaction is expected as verified through in vivo studies where no inhibition of metabolism of the following active substances was found: tricyclic antidepressant (representing mostly CYP2D6 pathway), warfarin (CYP2C9), theophylline (CYP1A2) or diazepam (CYP3A4 and 2C19).
Croatian: Stoga se ne očekuje nikakva posebna interakcija, što potvrđuju in vivo ispitivanja u kojima nije nađena inhibicija metabolizma sljedećih djelatnih tvari: tricikličkih antidepresiva (predstavljaju glavninu CYP2D6 puta), varfarina (CYP2C9), teofilina (CYP1A2) ili diazepama (CYP3A4 i 2C19).
English: The clinical consequences are likely to be limited, but clinical monitoring is recommended and an increase of olanzapine dose may be considered if necessary (see section 4.2).
Croatian: Kliničke posljedice su vjerojatno ograničene, ali se preporučuje kliničko praćenje te se može razmotriti povećanje doze olanzapina ako je to potrebno (vidjeti dio 4.2).
English: Effects on haematology parameters were found in each species, including dose-related reductions in circulating leukocytes in mice and non-specific reductions of circulating leukocytes in rats; however, no evidence of bone marrow cytotoxicity was found.
Croatian: U svakoj su vrsti pronađeni učinci na hematološke parametre uključujući smanjenje broja cirkulirajućih leukocita ovisno o dozi u miševa te nespecifično smanjenje broja cirkulirajućih leukocita u štakora; međutim, nije nađena citotoksičnost na koštanu srž.
English: Studies in patients aged 13-17 years showed various adverse reactions, including weight gain, changes in metabolic parameters and increases in prolactin levels (see sections 4.8 and 5.1).
Croatian: Ispitivanja u bolesnika u dobi od 13 do 17 godina pokazala su različite nuspojave, uključujući povećanje tjelesne težine, promjene metaboličkih parametara te porast razina prolaktina (vidjeti dijelove 4.8 i 5.1).
English: Neutropenia has been reported commonly when olanzapine and valproate are used concomitantly (see section 4.8).
Croatian: Neutropenija je obično zabilježena kod istodobne primjene olanzapina i valproata (vidjeti dio 4.8).
English: Cytochromes P450CYP1A2 and P450-CYP2D6 contribute to the formation of the N-desmethyl and 2-hydroxymethyl metabolites, both exhibited significantly less in vivo pharmacological activity than olanzapine in animal studies.
Croatian: Citokromi P450-CYP1A2 i P450-CYP2D6 doprinose stvaranju N-desmetil i 2-hidroksimetil metabolita te u ispitivanjima na životinjama oba pokazuju značajno manje in vivo farmakološko djelovanje od olanzapina.
English: DRESS appears initially as flu-like symptoms with a rash on the face and then with an extended rash, high temperature, enlarged lymph nodes, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cells (eosinophilia).
Croatian: DRESS se na početku očituje simptomima nalik gripi s osipom po licu, a kasnije i proširenim osipom, visokom temperaturom, povećanim limfnih čvorovima, povišenim razinama jetrenih enzima koji su vidljivi u krvnim pretragama te povećanjem broja jedne vrste bijelih krvnih stanica (eozinofilija).
English: If this happens, contact your doctor at once.
Croatian: Ako do ovog dođe, odmah se obratite svom liječniku.
English: Schizophrenia: The recommended starting dose for olanzapine is 10 mg/day.
Croatian: Odrasli Shizofrenija: preporučena početna doza olanzapina je 10 mg/dan.
English: If a new manic, mixed, or depressive episode occurs, olanzapine treatment should be continued (with dose optimisation as needed), with supplementary therapy to treat mood symptoms, as clinically indicated.
Croatian: Ako dođe do nove manične, miješane ili depresivne epizode, liječenje olanzapinom treba nastaviti (uz optimizaciju doze prema potrebi) uz dopunsku terapiju za liječenje simptoma poremećaja raspoloženja sukladno kliničkoj slici.
English: During treatment with olanzapine in combination with lithium or divalproex, an increase of  7 % from baseline body weight occurred in 17.4 % of patients during acute treatment (up to 6 weeks).
Croatian: Tijekom liječenja olanzapinom u kombinaciji s litijem ili divalproeksom, porast tjelesne težine ≥ 7 % od početne pojavio se u 17,4 % bolesnika tijekom akutnog liječenja (do 6 tjedana).
English: Olanzapine showed no interaction when co-administered with lithium or biperiden.
Croatian: Olanzapin nije pokazao interakciju kada se primjenjivao istodobno s litijem ili biperidenom.
English: Long-term olanzapine treatment (up to 12 months) for recurrence prevention in patients with bipolar disorder was associated with an increase of  7 % from baseline body weight in 39.9 % of patients.
Croatian: Dugotrajno liječenje olanzapinom (do 12 mjeseci) zbog prevencije relapsa u bolesnika s bipolarnim poremećajem bilo je povezano s povećanjem tjelesne težine ≥ 7 % od početne tjelesne težine u 39,9 % bolesnika.
English: Risk factors that may predispose this patient population to increased mortality include age >65 years, dysphagia, sedation, malnutrition and dehydration, pulmonary conditions (e.g., pneumonia, with or without aspiration), or concomitant use of benzodiazepines.
Croatian: Čimbenici rizika koji mogu pogodovati povećanom mortalitetu u ovoj populaciji bolesnika uključuju dob iznad 65 godina, disfagiju, sedaciju, malnutriciju i dehidraciju, bolesti pluća (npr. upala pluća sa ili bez aspiracije) ili istodobna primjena benzodiazepina.
English: • Parkinson's disease
Croatian: • Parkinsonova bolest
English: In a multinational, double-blind, comparative study of schizophrenia, schizoaffective, and related disorders which included 1,481 patients with varying degrees of associated depressive symptoms (baseline mean of 16.6 on the Montgomery-Asberg Depression Rating Scale), a prospective secondary analysis of baseline to endpoint mood score change demonstrated a statistically significant improvement (p=0.001) favouring olanzapine (-6.0) versus haloperidol (-3.1).
Croatian: U multinacionalnom, dvostruko slijepom, komparativnom ispitivanju shizofrenije, shizoafektivnih i povezanih poremećaja, koje je obuhvaćalo 1481 bolesnika s različitim stupnjevima pridruženih simptoma depresije (prosječna vrijednost 16,6 po Montgomery-Asberg ljestvici depresije), prospektivna sekundarna analiza vrijednosti promjene raspoloženja od početnog do krajnjeg pokazala je statistički značajno poboljšanje (p = 0,001) u korist olanzapina (-6,0) u odnosu na haloperidol (-3,1).
English: • The use of Olanzapine Mylan in elderly patients with dementia is not recommended as it may have serious side effects.
Croatian: • Primjena Olanzapine Mylan u starijih bolesnika s demencijom (zaboravljivošću) se ne preporučuje jer mogu nastati teške nuspojave.
English: Olanzapine also demonstrated comparable efficacy results to haloperidol in terms of the proportion of patients in symptomatic remission from mania and depression at 6 and 12 weeks.
Croatian: Olanzapin je također pokazao komparativne rezultate djelotvornosti u odnosu na haloperidol u smislu dijela bolesnika koji su u 6. i 12. tjednu liječenja pokazali simptomatsku remisiju manije i depresije.
English: The proportion of patients who had adverse, clinically significant changes in weight gain, glucose, total/LDL/HDL cholesterol or triglycerides increased over time.
Croatian: Udio bolesnika koji su imali klinički značajne nuspojave poput povećanja tjelesne težine, porasta vrijednosti glukoze, ukupnog/LDL/HDL kolesterola ili triglicerida, porastao je s vremenom.
English: • Very rarely, medicines of this type cause a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness.
Croatian: • Vrlo rijetko, lijekovi ovog tipa uzrokuju kombinaciju vrućice, ubrzanog disanja, znojenja, ukočenosti mišića te omamljenosti ili pospanosti.
English: In clinical trials, worsening of Parkinsonian symptomatology and hallucinations were reported very commonly and more frequently than with placebo (see section 4.8), and olanzapine was not more effective than placebo in the treatment of psychotic symptoms.
Croatian: U kliničkim ispitivanjima, pogoršanje simptoma parkinsonizma i halucinacije zabilježeni su vrlo često te češće u odnosu na placebo (vidjeti dio 4.8), a olanzapin nije bio učinkovitiji od placeba u liječenju psihotičkih simptoma.
English: Undesirable alterations in lipids have been observed in olanzapine-treated patients in placebocontrolled clinical trials (see section 4.8).
Croatian: Neželjene promjene vrijednosti lipida uočene su u bolesnika liječenih olanzapinom u placebo kontroliranim kliničkim ispitivanjima (vidjeti dio 4.8).
English: Seizures where in most cases a history of seizures or risk factors for seizures were reported11
Croatian: napadaji, u većini slučajeva kada su prijavljeni napadaji u anamnezi ili čimbenici rizika za nastanak napadaja11
English: Other medicines and Olanzapine Mylan
Croatian: Drugi lijekovi i Olanzapine Mylan
English: The concomitant use of olanzapine with anti-Parkinsonian medicinal products in patients with Parkinson's disease and dementia is not recommended (see section 4.4).
Croatian: Ne preporučuje se istodobna primjena olanzapina s antiparkinsonicima u bolesnika s parkinsonovom bolesti i demencijom (vidjeti dio 4.4).
English: Talk to your doctor or pharmacist before you take Olanzapine Mylan.
Croatian: Upozorenja i mjere opreza Obratite se svom liječniku ili ljekarniku prije nego uzmete Olanzapine Mylan.
English: • A blocked intestine (Paralytic ileus)
Croatian: • Zatvor crijeva (paralitički ileus)
English: New born infants exposed to antipsychotics (including olanzapine) during the third trimester of pregnancy are at risk of adverse reactions including extrapyramidal and/or withdrawal symptoms that may vary in severity and duration following delivery.
Croatian: U novorođenčadi izloženoj antipsihoticima (uključujući olanzapin) tijekom trećeg tromjesečja trudnoće postoji rizik od nastanka nuspojava, uključujući ekstrapiramidalne simptome i/ili simptome ustezanja koji mogu, nakon poroda, varirati po težini i trajanju.
English: Absolute oral bioavailability relative to intravenous administration has not been determined.
Croatian: Apsolutna bioraspoloživost peroralno primjenjenog lijeka u odnosu na intravenoznu primjenu nije ustanovljena.
English: Reversible neutropenia, thrombocytopenia, or anaemia developed in a few dogs treated with 8 or 10 mg/kg/day (total olanzapine exposure [AUC] is 12- to 15-fold greater than that of a man given a 12 mg dose).
Croatian: Reverzibilna neutropenija, trombocitopenija ili anemija razvile su se u malog broja pasa liječenih s 8 ili 10 mg/kg/dan (ukupna izloženost olanzapinu [AUC] je 12 do 15 puta veća nego izloženost u čovjeka kojemu je dana doza od 12 mg).
English: In cytopenic dogs, there were no adverse effects on progenitor and proliferating cells in the bone marrow.
Croatian: U pasa s citopenijom nije bilo štetnih učinaka na matičnim i proliferacijskim stanicama koštane srži.
English: In the same clinical trials, cerebrovascular adverse events (CVAE e.g., stroke, transient ischaemic attack), including fatalities, were reported.
Croatian: U istim kliničkim ispitivanjima zabilježeni su neželjeni cerebrovaskularni događaji (CV događaji, primjerice moždani udar, prolazni ishemijski napad) uključujući smrtne slučajeve.
English: The predominant pharmacologic activity is from the parent olanzapine.
Croatian: Prevladavajuće farmakološko djelovanje proizlazi iz izvornog olanzapina.
English: Patients treated with any antipsychotic medicines, including olanzapine, should be observed for signs and symptoms of hyperglycaemia (such as polydipsia, polyuria, polyphagia, and weakness) and patients with diabetes mellitus or with risk factors for diabetes mellitus should be monitored regularly for worsening of glucose control.
Croatian: U bolesnika liječenih bilo kojim antipsihotikom, uključujući olanzapin, treba pratiti pojavu znakova i simptoma hiperglikemije (kao što su polidipsija, poliurija, polifagija i slabost), a bolesnike s dijabetesom melitusom ili čimbenicima rizika za razvoj dijabetesa melitusa treba redovito pratiti zbog pogoršanja kontrole glukoze.
English: Olanzapine Mylan has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olanzapine treatment.
Croatian: Pokazalo se da Olanzapine Mylan sprječava ponavljanje tih simptoma u bolesnika s bipolarnim poremećajem čije su epizode manije reagirale na liječenje olanzapinom.
English: The plasma clearance of olanzapine is lower in elderly versus young subjects, in females versus males, and in non-smokers versus smokers.
Croatian: Klirens olanzapina u plazmi bio je niži u starijih nego u mlađih ispitanika, u žena nego u muškaraca te u nepušača nego pušača.
English: In one clinical trial in patients with bipolar mania, valproate combination therapy with olanzapine resulted in an incidence of neutropenia of 4.1 %; a potential contributing factor could be high plasma valproate levels.
Croatian: U jednom kliničkom ispitivanju u bolesnika s bipolarnom manijom, kombinacijska terapija valproata i olanzapina uzrokovala je incidenciju neutropenije od 4,1 %; mogući faktor koji je tome pridonio mogle su biti visoke razine valproata u plazmi.
English: Olanzapine was started at 2.5 mg/day and titrated to a maximum of 15 mg/day based on investigator judgement.
Croatian: Terapija olanzapinom započinje dozom od 2,5 mg na dan i titrira se na maksimalno 15 mg na dan na temelju stručne procjene ispitivača.
English: Very common symptoms in overdose (> 10 % incidence) include tachycardia, agitation/aggressiveness, dysarthria, various extrapyramidal symptoms, and reduced level of consciousness ranging from sedation to coma.
Croatian: Vrlo česti simptomi predoziranja (incidencija > 10 %) obuhvaćaju tahikardiju, agitaciju/agresivnost, dizartriju, različite ekstrapiramidalne simptome te smanjenu razinu svijesti u rasponu od sedacije do kome.
English: 14 Observed for fasting normal levels at baseline (< 1.016 mmol/l) which increased to high (≥ 1.467 mmol/l) and changes in fasting triglycerides from borderline at baseline (≥ 1.016 mmol/l< 1.467 mmol/l) to high (≥ 1.467 mmol/l).
Croatian: 14 Uočeno za normalne početne razine triglicerida natašte (< 1,016 mmol/l) koje su porasle na visoke razine (≥ 1,467 mmol/l) i promjene vrijednosti triglicerida natašte od početnih graničnih vrijednosti (≥ 1,016 mmol/l-< 1,467 mmol/l) do visokih vrijednosti (≥ 1,467 mmol/l).
English: - The active substance is olanzapine.
Croatian: - Djelatna tvar je olanzapin.
English: Thromboembolism (including pulmonary embolism and deep vein thrombosis) (see section
Croatian: tromboembolija (uključujući plućnu emboliju i duboku vensku trombozu) (vidjeti dio 4.4)
English: Hypothermia12
Croatian: hipotermija12
English: What Olanzapine Mylan looks like and contents of the pack
Croatian: Kako Olanzapine Mylan izgleda i sadržaj pakiranja
English: The use of olanzapine in the treatment of dopamine agonist associated psychosis in patients with Parkinson's disease is not recommended.
Croatian: Primjena olanzapina u liječenju psihoza povezanih s dopaminskim agonistima u bolesnika s Parkinsonovom bolešću se ne preporučuje.
English: Clinical monitoring is recommended and an increase of olanzapine dose may be considered if necessary (see section 4.5).
Croatian: Preporučuje se klinički nadzor, a po potrebi se može razmotriti i povećanje doze olanzapina (vidjeti dio 4.5).
English: The following table summarises the adverse reactions reported with a greater frequency in adolescent patients (aged 13-17 years) than in adult patients or adverse reactions only identified during short-term clinical trials in adolescent patients.
Croatian: Sljedeća tablica sažima nuspojave zabilježene s većom učestalosti u adolescentnih bolesnika (u dobi od 13 do 17 godina) u odnosu na odrasle bolesnike ili nuspojave identificirane samo u kratkotrajnim kliničkim ispitivanjima u adolescentnih bolesnika.
English: • Weight gain has been seen in patients taking Olanzapine Mylan.
Croatian: • Opaženo je povećanje tjelesne težine u bolesnika koji uzimaju Olanzapine Mylan.
English: The magnitude of changes in fasting total cholesterol, LDL cholesterol, triglycerides, and prolactin (see sections 4.4 and 4.8) were greater in adolescents than in adults.
Croatian: Veličine promjena vrijednosti ukupnog kolesterola natašte, LDL kolesterola, triglicerida i prolaktina bile su veće u adolescenata nego u odraslih (vidjeti dijelove 4.4 i 4.8).
English: - The other ingredients are: (tablet core) lactose monohydrate (see section 2 ‘Olanzapine contains lactose'), maize starch, preglatinised maize starch, crospovidone type A, magnesium stearate and (tablet coating) polyvinyl alcohol, titanium dioxide (E171), talc (E553b), soya lecithin (E322) (see section 2 ‘Olanzapine Mylan contains soya lecithin'), xanthan gum (E415).
Croatian: - Ostali sastojci su: (jezgra tablete) laktoza hidrat (pogledajte 2. odjeljak „Olanzapine sadrži laktozu”), kukuruzni škrob, prethodno gelirani kukuruzni škrob, krospovidon tipa A, magnezijev stearat i (ovojnica tablete) polivinilni alkohol, titanijev dioksid (E171), talk (E553b), sojin lecitin (E322) (pogledajte 2. odjeljak „Olanzapine Mylan sadrži sojin lecitin”), ksantanska guma (E415).
English: Potential for olanzapine to affect other medicinal products Olanzapine may antagonise the effects of direct and indirect dopamine agonists.
Croatian: Mogući utjecaj olanzapina na druge lijekove Olanzapin može antagonistički djelovati na učinke izravnih i neizravnih agonista dopamina.
English: Animal behavioural studies with olanzapine indicated 5HT, dopamine, and cholinergic antagonism, consistent with the receptor-binding profile.
Croatian: Ispitivanja ponašanja životinja koje su primale olanzapin ukazivala su na antagonizam s 5HT, dopaminom i kolinergicima u skladu s profilom vezanja na receptore.
English: However, caution should be exercised when olanzapine is prescribed with medicines known to increase QTc interval, especially in the elderly, in patients with congenital long QT syndrome, congestive heart failure, heart hypertrophy, hypokalaemia or hypomagnesaemia.
Croatian: No potreban je oprez ako se olanzapin uzima uz lijekove za koje je poznato da produljuju QTc interval, osobito u starijih bolesnika, u bolesnika s prirođenim dugim QT sindromom, kongestivnim zatajenjem srca, hipertrofijom srca, hipokalemijom ili hipomagnezijemijom.
English: Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the metabolism of olanzapine.
Croatian: Dokazano je da fluvoksamin, specifični inhibitor CYP1A2, značajno inhibira metabolizam olanzapina.
English: Given the primary CNS effects of olanzapine, caution should be used when it is taken in combination with other centrally acting medicines and alcohol.
Croatian: S obzirom na učinak olanzapina na središnji živčani sustav potreban je oprez ako se koristi u kombinaciji s ostalim lijekovima sa središnjim djelovanjem te alkoholom.
English: Standard procedures for management of overdose may be indicated (i.e. gastric lavage, administration of activated charcoal).
Croatian: Mogu biti indicirani standardni postupci liječenja predoziranja (npr. ispiranje želuca, primjena aktivnog ugljena).